Search results for "Rigaku Analytical Devices"
Selected Filters:
Hematology Staining Solutions
Merck KGaA, Darmstadt, GermanyComplete range of standard solutions and rapid staining kits. Cytochemical method support. Ready-to-use products. In Vitro Diagnostic Medical Devices (IVD) registered and Community of Europe (CE) certified. Brilliant images and contrasts. Stable results with pH-buffered solutions. Panoptic methods Merck Millipore offers all standard staining solutions, such as Giemsa, Leishman, Wright or May-Grünwald,…
Marianas™
Intelligent Imaging Innovations (3i)The Marianas™ research microscopy imaging system combines state-of-the-art optics, custom electronics, detectors, and computers for both live and fixed cell applications. 3i’s SlideBook™ software takes full advantage of the system's automation by seamlessly integrating components, including x-,y- and z-stage motion, filter control and light shuttering. Methods: • 7D imaging • FRET • TIRF • FLIM • Ratiometric imaging • Photoman…
tiamo™
Metrohm AGtiamo™ is a control and database software for titrators and dosing devices as well as for complete laboratory automation, including client-server systems. The name tiamo™ stands for «titration and more» – tiamo™ can do more than just titrate. tiamo™ is a titration network (NTDS = Networked Titration Data System). The modern user interface makes it easy for you to familiarize yourself with tiamo™. All the commands and controls…
FDA clears Siemens Healthineers' bedside computed tomography scanner
The Somatom scanner is equipped with a forward-looking camera and motorized wheels, allowing a single technologist to navigate the device through hospital hallways
Microsampling redefines patient-centric approaches to bioanalysis
PPD Laboratory services embraces microsampling for enhanced client and patient benefits
On-site identification and detection of narcotics with Raman analyzers
Rigaku to present portfolio of handheld Raman analyzers at IACP annual conference and exposition
binx health submits request for Emergency Use Authorization for first CRISPR-based point-of-care test for COVID-19
Platform poised to be first CLIA-waived CRISPR-based, point-of-care COVID-19 device with central-lab performance, developed in collaboration with Sherlock Biosciences














